Wird geladen...
Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
BACKGROUND: Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X‐linked disease caused by a deficiency of the lysosomal enzyme iduronate‐2‐sulfatase, which catalyses a step in the catabolism of glycosaminoglycans. The glycosaminoglycans accumulate within tissues affecting multiple o...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2016
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173756/ https://ncbi.nlm.nih.gov/pubmed/26845288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008185.pub4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|